Angelika Zabel-du Bois1,2,3, Mechthild Wagner-Ecker4, Stefanie Milker-Zabel5, Christian Schwager4, Ute Wirkner4, Jürgen Debus5, Amir Abdollahi4,5,6, Peter E Huber4. 1. Department of Radiation Oncology, German Cancer Research Center, Heidelberg, Germany. A.Zabel@dkfz-heidelberg.de. 2. Department of RadioOncology, University of Heidelberg, Heidelberg, Germany. A.Zabel@dkfz-heidelberg.de. 3. Department of Radiation Oncology (E050), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. A.Zabel@dkfz-heidelberg.de. 4. Department of Radiation Oncology, German Cancer Research Center, Heidelberg, Germany. 5. Department of RadioOncology, University of Heidelberg, Heidelberg, Germany. 6. Center of Cancer Systems Biology, NASA Specialized Center of Research, Caritas St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA, USA.
Abstract
PURPOSE: To unravel biological mechanisms potentially resulting in the obliteration process after radiosurgery (RS) of human cerebral arteriovenous malformations (AVMs) by investigating molecular signatures on the transcriptomic level in peripheral blood of patients. PATIENTS AND METHODS: Venous blood samples were obtained at definite points of time before and after RS. The samples were tested for radiation-induced changes regarding biological markers (mRNA) using cDNA and oligo-microarray technology. The corresponding expression profiles were correlated with clinical data and obliteration signs in radiologic imaging. RESULTS: The proof of principle that RS outcome can be successfully correlated with transcriptomics of cellular blood components as disease parameter was demonstrated. The authors identified 76 differentially regulated genes (p < 0.001) after RS. Interestingly, in particular genes with known roles in anti-angiogenic and pro-coagulative pathways were identified as potentially relevant. In particularly, the authors found a significant downregulation of neuropilin-2, protein C inhibitor and cyclin-dependent kinase 6. They also found that low pretreatment blood mRNA levels of TLR4 (toll-like receptor 4) and STAT3 (signal transducer and activator of transcription 3) correlated with fast obliteration of AVMs. CONCLUSION: The authors report on a novel technique for molecular biological analysis of blood from patients with cerebral AVM treated with RS. Differential regulation of genes in peripheral blood was successfully correlated with RS and time to obliteration of AVMs. The identified genes indicate a potential new methodology to monitor RS, which may result in an individualized therapy and optimized follow-up.
PURPOSE: To unravel biological mechanisms potentially resulting in the obliteration process after radiosurgery (RS) of humancerebral arteriovenous malformations (AVMs) by investigating molecular signatures on the transcriptomic level in peripheral blood of patients. PATIENTS AND METHODS: Venous blood samples were obtained at definite points of time before and after RS. The samples were tested for radiation-induced changes regarding biological markers (mRNA) using cDNA and oligo-microarray technology. The corresponding expression profiles were correlated with clinical data and obliteration signs in radiologic imaging. RESULTS: The proof of principle that RS outcome can be successfully correlated with transcriptomics of cellular blood components as disease parameter was demonstrated. The authors identified 76 differentially regulated genes (p < 0.001) after RS. Interestingly, in particular genes with known roles in anti-angiogenic and pro-coagulative pathways were identified as potentially relevant. In particularly, the authors found a significant downregulation of neuropilin-2, protein C inhibitor and cyclin-dependent kinase 6. They also found that low pretreatment blood mRNA levels of TLR4 (toll-like receptor 4) and STAT3 (signal transducer and activator of transcription 3) correlated with fast obliteration of AVMs. CONCLUSION: The authors report on a novel technique for molecular biological analysis of blood from patients with cerebral AVM treated with RS. Differential regulation of genes in peripheral blood was successfully correlated with RS and time to obliteration of AVMs. The identified genes indicate a potential new methodology to monitor RS, which may result in an individualized therapy and optimized follow-up.
Authors: Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe Journal: Nat Med Date: 2007-10-21 Impact factor: 53.440
Authors: Amir Abdollahi; Christian Schwager; Jörg Kleeff; Irene Esposito; Sophie Domhan; Peter Peschke; Kai Hauser; Philip Hahnfeldt; Lynn Hlatky; Jürgen Debus; Jeffrey M Peters; Helmut Friess; Judah Folkman; Peter E Huber Journal: Proc Natl Acad Sci U S A Date: 2007-07-24 Impact factor: 11.205
Authors: Seyer Safi; Philipp Beckhove; Arne Warth; Axel Benner; Falk Roeder; Stefan Rieken; Juergen Debus; Hendrik Dienemann; Hans Hoffmann; Peter E Huber Journal: BMC Cancer Date: 2015-12-19 Impact factor: 4.430
Authors: Maximilian Knoll; Maria Waltenberger; Jennifer Furkel; Ute Wirkner; Aoife Ward Gahlawat; Ivana Dokic; Christian Schwager; Sebastian Adeberg; Stefan Rieken; Tobias Kessler; Felix Sahm; Laila König; Christel Herold-Mende; Stephanie E Combs; Jürgen Debus; Amir Abdollahi Journal: Cancers (Basel) Date: 2022-01-28 Impact factor: 6.639
Authors: Maria Waltenberger; Jennifer Furkel; Manuel Röhrich; Patrick Salome; Charlotte Debus; Bouchra Tawk; Aoife Ward Gahlawat; Andreas Kudak; Matthias Dostal; Ute Wirkner; Christian Schwager; Christel Herold-Mende; Stephanie E Combs; Laila König; Jürgen Debus; Uwe Haberkorn; Amir Abdollahi; Maximilian Knoll Journal: Front Oncol Date: 2022-09-20 Impact factor: 5.738